Deerfield To Go As Takeda Plans Realignment Of Post-Shire US Ops

Takeda is to close down and relocate one of its main US sites, with unspecified job losses, as it plans post-Shire restructuring, while in Japan vocal opposition to the acquisition rises.

Business reengineering
TAKEDA TO SHUT DEERFIELD SITE • Source: Shutterstock

Takeda Pharmaceutical Co. Ltd. is to close down one of its main sites in the US, relocating and rationalizing most functions, as it continues to implement restructuring around its planned $62.4bn acquisition of Shire PLC.

Activities at the Deerfield, Illinois site, which acts as the major Japanese firm's main US headquarters and currently employs nearly...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip